Search results for "VACCINE"

showing 10 items of 801 documents

The impact of mandatory vaccination law in Italy on mmr coverage rates in two of the largest italian regions (Emilia-romagna and sicily): An effectiv…

2020

Background: Vaccine hesitancy has increased worldwide, leading to reduction in vaccination coverage rates. In particular, reduction in the coverage for the trivalent Measles-Mumps-Rubella vaccine has led to an increase of measles cases. The aim of this study is to analyze the coverage rates for the MMR vaccine in the Emilia-Romagna Region (RER) and Sicily Region (SR) between 2009 and 2018, and to correlate any significant change to index events which could have modified the trend of vaccination rates. Methods: Official aggregate data on vaccination coverage at 24 months provided by the RER and the SR were analyzed through trend analysis and related to important index events. Results: The tw…

Pharmacologylcsh:RImmunologycoverage rateslcsh:MedicineMMR vaccinemedicine.diseaseMandatory vaccinationMeaslesArticleVaccinationMandatory vaccinationTrend analysisInfectious DiseasesGeographyVaccination coverageDrug DiscoverymedicinePharmacology (medical)Aggregate datamandatory vaccinationsCoverage rateVaccine hesitancyDemography
researchProduct

Acceptability of HPV Vaccination in Young Students by Exploring Health Belief Model and Health Literacy

2022

Evidence on the human papillomavirus (HPV) vaccine shows that it is effective in reducing the burden of HPV-related diseases. For more than 15 years the HPV vaccine has been offered free of charge in Italy to girls from the age of 12. Over time, the free offer of the HPV vaccine has also been extended to boys and to young adults at risk of developing HPV lesions. Despite the HPV vaccine’s effectiveness and availability, vaccination coverage is low in Italy, with a reported value of 46.5% in 2020. Furthermore, in the southern administrative regions, vaccination coverage is even lower than national values, with 25.9% coverage in Sicily. A cross-sectional study was conducted among university a…

Pharmacologylow vaccination coverageInfectious Diseasesvaccine sources of information.Drug DiscoveryImmunologyPharmacology (medical)Settore MED/42 - Igiene Generale E ApplicataHPV vaccine; behavioral model; Health Belief Model; health literacy; vaccine sources of information; low vaccination coveragehealth literacyHPV vaccineHealth Belief Modelbehavioral modelVaccines; Volume 10; Issue 7; Pages: 998
researchProduct

Knowledge of and attitudes to influenza in unvaccinated primary care physicians and nurses

2014

Primary healthcare workers, especially nurses, are exposed to the vast majority of patients with influenza and play an important role in vaccinating patients. Healthcare workers' misconceptions about influenza and influenza vaccination have been reported as possible factors associated with lack of vaccination. The objective of this study was to compare the characteristics of unvaccinated physicians and unvaccinated nurses in the 2011-2012 influenza season. We performed an anonymous web survey of Spanish primary healthcare workers in 2012. Information was collected on vaccination and knowledge of and attitudes to the influenza vaccine. Multivariate analysis was performed using unconditional …

Pharmacologymedicine.medical_specialtyMultivariate analysisbusiness.industryCross-sectional studyInfluenza vaccineImmunologyPrimary careLogistic regressionVaccinationNursingFamily medicineHealth careImmunology and AllergyMedicinebusinessWeb surveyHuman Vaccines & Immunotherapeutics
researchProduct

Real life hexavalent vaccination among children as a practical guide for public health professionals: Four years (from 2016 to 2019) of clinical prac…

2022

Hexavalent (HV) vaccination is a priority for newborn protection and in Italy is included in the National Immunization Plan with a three doses cycle at 61, 121 and 301 days of age. A retrospective clinical study has been conducted to evaluate real life clinical practice of HV vaccination in the fourth most populous Italian Region. Data on the completion of the HV cycle, on the interchangeability between the two HV adopted in 2016–2017 (DTaP3-IPV-HB/Hib) and 2018–2019 (DTaP5-IPV-HB-Hib) and on the use above the established age, were collected in five Sicilian Local Health Authorities. Data showed an average 91.5% completion of the vaccination cycle at 24 months of age. The average age of adm…

Pharmacologyvaccination coverage.ImmunologyVaccinationInfantPoliovirus Vaccine InactivatedChild PreschoolImmunology and AllergyHumansHepatitis B VaccinesPublic HealthVaccines CombinedHexavalent vaccineChildSicilyreal-life vaccinationDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleinterchangeabilityHaemophilus VaccinesRetrospective Studiesco-administration
researchProduct

Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults.

2010

International audience; In the present pilot study, intradermal ID delivery systems with a BD microneedle from 1 to 3mm in length, and epidermal delivery (BD skin abrader) through abraded skin surface relative to standard intramuscular injection were evaluated. Circulating neutralizing antibodies were measured against the rabies virus after the Vero cells rabies vaccine was administered at D0, D7, D21 and D49. This clinical evaluation in 66 healthy volunteers shows that ID delivery using BD microneedle technology of 1/4 the IM antigen dose is safe, efficient and reliable, resulting in a protective seroconversion rate. In contrast, the epidermal delivery route did not produce an immune respo…

Pilot Projectsmedicine.disease_causeAntibodies ViralMESH: Antibodies Neutralizing0302 clinical medicineRabies vaccine030212 general & internal medicineViralMononegaviralesNeutralizingSkin0303 health sciencesIntramuscularbiologyintegumentary systemVaccinationMESH: Rabies VaccinesMESH: Injections Intramuscular3. Good healthVaccinationInfectious DiseasesNeedlesMESH: Young Adult[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyMolecular MedicineFemalemedicine.drugAdultInjections IntradermalAdolescentRabiesInjections IntramuscularAntibodiesInjections03 medical and health sciencesYoung AdultMESH: RabiesMESH: SkinIntradermalmedicineHumansSeroconversionLyssavirus030304 developmental biologyMESH: AdolescentMESH: Injections IntradermalMESH: HumansGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryRabies virusPublic Health Environmental and Occupational HealthMESH: AdultMESH: VaccinationRhabdoviridaebiology.organism_classificationmedicine.diseaseMESH: Pilot ProjectsVirologyAntibodies NeutralizingRabies VaccinesMESH: NeedlesImmunologyRabiesbusinessMESH: FemaleMESH: Antibodies Viral
researchProduct

Clinical recrudescence of chronic untreated P. malariae infection after BNT162b2 CoVID-19 vaccine

2022

We described a case of clinical reactivation of chronic P. malariae infection following CoVID-19 vaccination with BNT162b2 (Pifzer-Biontech CoVID-19 vaccine) in a 48-year old Italian man.The patient came to our attention for fever of unknown origin show a quartan pattern (every third day) associated to splenomegaly, the onset of the fever occurred one month after CoVID-19 vaccination with BNT162b2. P. malariae was diagnosed using CarestartTM malaria rapid test and Polymerase-Chain Reaction. Post-vaccine transient reduction of immune reactivity is described in literature, although the mechanism is unknown.(c) 2022 Published by Elsevier Ltd.CC_BY_NC_ND_4.0

Plasmodium malariaeInfectious DiseasesPlasmodium malariae.BNT162b2Chronic malariaBNT162b2; Chronic malaria; CoVID-19 vaccine; Malaria; Plasmodium malariaeCoVID-19 vaccineMalariaIDCases
researchProduct

Monitoring serologic response to single in ovo vaccination with an immune complex vaccine against infectious bursal disease in broilers

2021

Este artículo se encuentra disponible en la siguiente URL: https://www.sciencedirect.com/science/article/pii/S003257912100033X The infectious bursal disease (IBD) virus is one of the most resistant and prevalent virus worldwide in the poultry industry, being vaccination the main tool to control the disease. For this reason, consistent and uniform immunization of broiler flocks against IBD is necessary to avoid the disease spreading. The aim of this study was to apply and assess an epidemiologic mapping tool focused on the immunization by in ovo single broiler vaccination using an immune complex IBD vaccine. With this regard, 7,576 serum samples were collected from 603 broiler flocks raised …

Pollos - Inmunología.animal diseasesChickens - Vaccination.IBDAntigen-Antibody ComplexChick EmbryoAntibodies ViralIn ovobroilerInfectious bursal disease virusSerologyInfectious bursal diseaseGeoServerIMMUNOLOGY HEALTH AND DISEASEAnimalsMedicineSeroprevalenceAves de corral - Enfermedades.Poultry - Diseases.Pollos - Enfermedades.Poultry DiseasesOvumlcsh:SF1-1100business.industryViral VaccinesGeneral MedicineBirnaviridae Infectionsmedicine.diseasevaccinationVaccinationTiterImmunizationChickens - Diseases.ImmunologyChickens - Immunology.Animal Science and ZoologyELISAFlocklcsh:Animal culturePollos - Vacunación.businessChickens
researchProduct

Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune Modula…

2021

Small-molecular Toll-like receptor 7/8 (TLR7/8) agonists hold promise as immune modulators for a variety of immune therapeutic purposes including cancer therapy or vaccination. However, due to their rapid systemic distribution causing difficult-to-control inflammatory off-target effects, their application is still problematic, in particular systemically. To address this problem, we designed and robustly fabricated pH-responsive nanogels serving as versatile immunodrug nanocarriers for safe delivery of TLR7/8-stimulating imidazoquinolines after intravenous administration. To this aim, a primary amine-reactive methacrylamide monomer bearing a pendant squaric ester amide is introduced, which i…

Polymersmedicine.medical_treatmentNanogelsVACCINEPharmacology010402 general chemistry01 natural sciencesBiochemistryMicelleCatalysisArticlePolymerizationchemistry.chemical_compoundColloid and Surface ChemistryAdjuvants ImmunologicSDG 3 - Good Health and Well-beingmedicineMedicine and Health SciencesAnimalsHumansReversible addition−fragmentation chain-transfer polymerizationMicellesTLR8AMIDESDrug CarriersMice Inbred BALB CChemistryOptical ImagingBiology and Life SciencesEstersGeneral ChemistryTLR7Hydrogen-Ion Concentration0104 chemical sciencesImidazoquinolineDrug LiberationCONJUGATIONToll-Like Receptor 7Toll-Like Receptor 8Systemic administrationImmunotherapyNanocarriersADJUVANTSAdjuvantNanogel
researchProduct

Breastfeeding and COVID-19 vaccination: position statement of the Italian scientific societies

2021

AbstractThe availability of a COVID-19 vaccine has raised the issue of its compatibility with breastfeeding. Consequently, the Italian Society of Neonatology (SIN), the Italian Society of Pediatrics (SIP), the Italian Society of Perinatal Medicine (SIMP), the Italian Society of Obstetrics and Gynecology (SIGO), the Italian Association of Hospital Obstetricians-Gynecologists (AOGOI) and the Italian Society of Infectious and Tropical Diseases (SIMIT) have made an ad hoc consensus statement. Currently, knowledge regarding the administration of COVID-19 vaccine to the breastfeeding mother is limited. Nevertheless, as health benefits of breastfeeding are well demonstrated and since biological pl…

Position statementmedicine.medical_specialtyCOVID-19 VaccinesConsensusCoronavirus disease 2019 (COVID-19)BreastfeedingBreastfeedingConsensuHealth benefits03 medical and health sciences0302 clinical medicineObstetrics and gynaecology030225 pediatricsMedicalMedicineHumans030212 general & internal medicineVaccination.Societies Medicalbusiness.industryVaccinationlcsh:RJ1-570COVID-19lcsh:PediatricsBreastfeeding; COVID-19; Vaccination; COVID-19; Consensus; Female; Humans; Italy; Societies Medical; Breast Feeding; COVID-19 VaccinesSettore MED/38VaccinationBreast FeedingItalyFamily medicineCommentaryFemaleBiological plausibilitybusinessSocietiesBreast feedingHuman
researchProduct

Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemothera…

2003

Globally, Streptococcus pneumoniae is a leading cause of invasive and noninvasive disease in infants and young children. The emergence of antibiotic-resistant strains has increased interest in prevention through immunization. Currently, the only available conjugate pneumococcal vaccine is a seven-valent formulation, PNCRM7. This paper presents excerpts from a symposium that provided an update of ongoing surveillance data and clinical trials evaluating pneumococcal conjugate vaccines. The topics addressed included: (1) PNCRM7 postmarketing safety data; (2) the impact of PNCRM7 in premature infants; (3) the direct and indirect effect of pneumococcal conjugate vaccines on colonization; (4) the…

Potential impactChemotherapymedicine.medical_specialtyGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industrymedicine.medical_treatmentPublic Health Environmental and Occupational HealthAntimicrobialmedicine.disease_causeClinical trialInfectious DiseasesPneumococcal vaccineImmunizationStreptococcus pneumoniaeImmunologyMolecular MedicineMedicinebusinessIntensive care medicineConjugateVaccine
researchProduct